HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.

Abstract
The Ca2+ overload by Ca2+ influx via Na+/Ca2+ exchanger (NCX) is a critical mechanism in myocardial ischemia/reperfusion injury. We investigated protective effects of a novel selective inhibitor of NCX, SEA0400, on cardiac function and energy metabolism during ischemia and reperfusion. Langendorff-perfused rat hearts were exposed to 35 minutes global ischemia and 40 minutes reperfusion. Using 31P nuclear magnetic resonance spectroscopy, cardiac phosphocreatine (PCr), ATP, and pHi were monitored. SEA0400 did not change the basic cardiac function, but improved the recovery of left ventricular developed pressure (LVDP) after reperfusion (27.6 +/- 4.9 mm Hg in control, 101.2 +/- 19.3 mm Hg in 0.1 microM, and 115.5 +/- 13.3 mm Hg in 1 microM SEA0400, means +/- SE, n = 6, P < 0.05). SEA0400 reduced left ventricular end-diastolic pressure and increased coronary flow after reperfusion. SEA0400 improved the recoveries of cardiac phosphocreatine and ATP after reperfusion, but did not affect pHi. There were significant linear correlations between left ventricular developed pressure and cardiac phosphocreatine (r = 0.79, P < 0.05), and left ventricular developed pressure and ATP (r = 0.80, P < 0.05). However, SEA0400 increased the incidence and duration of reperfusion ventricular arrhythmias. SEA0400 added only after reperfusion also improved both the contractile function and energy metabolism. It is concluded that the selective inhibition of NCX may be effective to preserve high-energy phosphates and to improve cardiac function after reperfusion, but may not be able to prevent fatal arrhythmias.
AuthorsNiu Chun Feng, Hiroshi Satoh, Tsuyoshi Urushida, Hideki Katoh, Hajime Terada, Yasuhide Watanabe, Hideharu Hayashi
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 47 Issue 2 Pg. 263-70 (Feb 2006) ISSN: 0160-2446 [Print] United States
PMID16495765 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aniline Compounds
  • Phenyl Ethers
  • Phosphates
  • SEA 0400
  • Sodium-Calcium Exchanger
  • Phosphocreatine
  • phosphocreatinine
  • Adenosine Triphosphate
  • Sodium
  • Calcium
Topics
  • Action Potentials (drug effects)
  • Adenosine Triphosphate (analysis)
  • Aniline Compounds (pharmacology)
  • Animals
  • Calcium (metabolism)
  • Dose-Response Relationship, Drug
  • Energy Metabolism
  • Hydrogen-Ion Concentration
  • Male
  • Myocardial Contraction (drug effects)
  • Myocardial Reperfusion Injury (etiology, prevention & control)
  • Myocardium (metabolism)
  • Nuclear Magnetic Resonance, Biomolecular
  • Perfusion
  • Phenyl Ethers (pharmacology)
  • Phosphates (analysis)
  • Phosphocreatine (analogs & derivatives, analysis)
  • Rats
  • Rats, Sprague-Dawley
  • Sodium (metabolism)
  • Sodium-Calcium Exchanger (antagonists & inhibitors)
  • Ventricular Function, Left (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: